红日药业

300026 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

10.3B ($1.5B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

5.8B

Net Income

22.9M

Gross Margin

N/A

Op. Margin

0.6%

Net Margin

0.4%

ROE

0.3%

ROA

0.2%

D/E

0.27

Dividend Yield

N/A

EPS

0.01

Current Ratio

3.79

Price History

Company Info

Industry	C27医药制造业
Market Segment	ChiNext
Currency	CNY
Fiscal Year	2024

Business Overview

Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves the fields of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases. The company was founded in 1996 and is headquartered in Tianjin, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 红日药业

Ticker	300026
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业